Daojia Z. Miao
Union Hospital
Wuhan, 430022, China
Wuhan, 430022, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Immunotherapy Landscape of Advanced Clear Cell Renal Cell Carcinoma: Targeting the Cancer-Immunity Cycle and Future Perspectives.
Journal: Biomedicines
Published: April 21, 2026
Rho/ROCK Signaling Pathway in Kidney Diseases: Mechanisms and Therapeutic Perspectives.
Journal: Biomedicines
Published: February 03, 2026
PEBP4 alleviates muscle wasting in lung cancer cachexia via KEAP1-NRF2-mediated redox homeostasis.
Journal: Cell death & disease
Published: November 17, 2025
OSCAR functions as a collagen I receptor to suppress hippo signaling and reprogram lipid metabolism in clear-cell renal cell carcinoma.
Journal: Cell death & disease
Published: November 11, 2025
Colorectal cancer stem cells crosstalk in tumor immune microenvironment and targeted therapeutic strategies.
Journal: Frontiers in immunology
Published: September 28, 2025
UBL3 governs VEGFR inhibitor resistance by activating NOTCH signaling in renal cell carcinoma.
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: September 09, 2025
Therapeutic advances in ureteral stricture: lessons from radiation-induced fibrosis to regenerative strategies-a narrative review.
Journal: Therapeutic advances in urology
Published: August 20, 2025
Emerging roles of metabolic biomarkers in renal cell carcinoma: from molecular mechanisms to clinical implications.
Journal: Frontiers in cell and developmental biology
Published: July 11, 2025
Targeting MMA-induced USP36 methylmalonylation to suppress macrophage polarization and tumor progression in clear-cell renal cell carcinoma.
Journal: Cell death and differentiation
Published: March 12, 2025
Epigenetically silenced KAT2B suppresses de novo lipogenesis through destroying HDAC5/LSD1 complex assembly in renal cell carcinoma.
Journal: Journal of advanced research
Published: January 14, 2025
Identification of the LCOR-PLCL1 pathway that restrains lipid accumulation and tumor progression in clear cell renal cell carcinoma.
Journal: International journal of biological sciences
Published: December 01, 2024
Publisher Correction: N6-methyladenosine-modified ALDH9A1 modulates lipid accumulation and tumor progression in clear cell renal cell carcinoma through the NPM1/IQGAP2/AKT signaling pathway.
Journal: Cell death & disease
Published: August 29, 2024
Last Updated: 09/26/2026